Founders, investors, and support organizations active in Pharma.
Azafaros is a clinical-stage biotech company developing oral therapies for rare genetic metabolic disorders, including lysosomal diseases. Its lead development strategy focuses on compounds designed to cross the blood-brain barrier and address severe neurological progression in underserved pediatric conditions.
Founded 2008. Specialist VC investing in biotech, pharma, and medical devices with a transatlantic presence.
Hemab is a clinical-stage biotech company developing prophylactic therapies for severe bleeding and thrombotic disorders. Founded by biotech operators with Novo Nordisk roots, the company engineers antibody-based treatments aimed at preventing episodes before they occur in underserved rare-disease populations.
Dedicated summit for mRNA-based therapeutics, focusing on R&D, manufacturing, and clinical applications in Europe.